Clinical Trial Update: A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing GZR101 Injection OD and GZR33-70 Injection OD for Type 2 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR101 Injection
• GZR33-70 Injection

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Type 2 Diabetes | Phase 2 | Status: RECRUITING